Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in Terns Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- +3 vs. Q3 2021
- Shares held
- 16.5M
- −221.7K (−1.3%) vs. Q3 2021
- Total value
- $116.7M
- −$57.6M (−33.1%) vs. Q3 2021
- New holders
- 6
- 16 more added
- Sold out
- 3
- 6 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameritas Investment Partners, Inc. | 708 | $5.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,279 | $9.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,543 | $11.0K | 0.00% | +784+103.3% | Added |
| Royal Bank of Canada | 3,074 | $22.0K | 0.00% | +1,323+75.6% | Added |
| UBS Group AG | 3,775 | $27.0K | 0.00% | +3,775 | New |
| Citigroup Inc | 4,286 | $30.0K | 0.00% | +2,694+169.2% | Added |
| Wells Fargo & Company | 5,479 | $39.0K | 0.00% | +5,464+36,426.7% | Added |
| New York State Common Retirement Fund | 5,918 | $42.0K | 0.00% | +44+0.7% | Added |
| American International Group, Inc. | 7,289 | $52.0K | 0.00% | −218−2.9% | Reduced |
| JPMorgan Chase & Co | 7,444 | $52.0K | 0.00% | +2,190+41.7% | Added |
| California State Teachers Retirement System | 8,160 | $58.0K | 0.00% | +3,521+75.9% | Added |
| Bank of America Corp | 8,585 | $61.0K | 0.00% | +3,453+67.3% | Added |
| Deutsche Bank AG | 8,911 | $63.0K | 0.00% | +440+5.2% | Added |
| Nuveen Asset Management, LLC | 14,237 | $83.0K | 0.00% | 00.0% | Unchanged |
| Parametric Portfolio Associates LLC | 12,317 | $87.0K | 0.00% | +12,317 | New |
| Goldman Sachs Group Inc | 15,208 | $108.0K | 0.00% | +15,208 | New |
| Marquette Asset Management, LLC | 16,619 | $117.0K | 0.02% | +16,619 | New |
| Charles Schwab Investment Management Inc | 28,746 | $204.0K | 0.00% | −2,797−8.9% | Reduced |
| Bank of New York Mellon Corp | 35,700 | $253.0K | 0.00% | +8,187+29.8% | Added |
| Millennium Management LLC | 53,281 | $377.0K | 0.00% | +53,281 | New |
| Jacobs Levy Equity Management, Inc | 55,222 | $390.0K | 0.00% | −32,312−36.9% | Reduced |
| Cowen and Company, LLC | 85,000 | $601.0K | 0.06% | 00.0% | Unchanged |
| Caas Capital Management LP | 85,851 | $607.0K | 0.06% | 00.0% | Unchanged |
| Morgan Stanley | 89,456 | $632.0K | 0.00% | +63,412+243.5% | Added |
| Bridgeway Capital Management, LLC | 95,500 | $675.0K | 0.01% | +95,500 | New |
| Northern Trust Corp | 112,036 | $792.0K | 0.00% | −4,880−4.2% | Reduced |
| State Street Corp | 162,019 | $1.15M | 0.00% | +11,679+7.8% | Added |
| Geode Capital Management, LLC | 180,935 | $1.28M | 0.00% | −12,401−6.4% | Reduced |
| Samsara BioCapital, LLC | 289,068 | $2.04M | 0.41% | 00.0% | Unchanged |
| Vanguard Group Inc | 558,327 | $3.95M | 0.00% | +117,655+26.7% | Added |
| BlackRock Inc. | 745,535 | $5.27M | 0.00% | +142,979+23.7% | Added |
| Antara Capital LP | 949,834 | $6.71M | 0.65% | +175,000+22.6% | Added |
| Suvretta Capital Management, LLC | 1,238,800 | $8.76M | 0.17% | +113,064+10.0% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,345,959 | $16.6M | 0.35% | 00.0% | Unchanged |
| Vivo Capital, LLC | 2,675,133 | $18.9M | 1.14% | 00.0% | Unchanged |
| FMR LLC | 2,800,985 | $19.8M | 0.00% | −132,177−4.5% | Reduced |
| OrbiMed Advisors LLC | 3,791,204 | $26.8M | 0.35% | 00.0% | Unchanged |
| Matthews International Capital Management LLC | 0 | $0 | 0.00% | −875,068−100.0% | Sold out |
| S&T Bank | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −400−100.0% | Sold out |